Beginning July 1 and running through the end of 2027, a new pilot program will allow some Medicare Part D prescription plan members who want to shed excess pounds and maintain weight loss to get Wegovy injections and tablets, Foundayo tablets or the Zepbound KwikPen for a $50 monthly copay
In recent years, the rise of obesity and related health issues has prompted a greater focus on effective treatment options
Its a tool for calorie control, not a magic metabolic pill and if its tanking your protein intake, it might be doing more harm than good for your muscle mass
Why this matters GLP-1 is on the tip of many peoples tongues because medications that act on the GLP-1 receptor produce strong effects on appetite, weight, and blood sugar
The dose of retatrutide matters enormously here because higher doses mean more glucagon receptor activation and proportionally greater heart rate effects
For us, this is a brand-new tool in our toolbox to benefit the quality of life in these patients." While GLP-1s are being seen as the hearts newest best friend, on the flip side, obesity is one of its worst enemies
